HN2008001793A - Enzima mdo modificada y metodo para su utilizacion - Google Patents

Enzima mdo modificada y metodo para su utilizacion

Info

Publication number
HN2008001793A
HN2008001793A HN2008001793A HN2008001793A HN2008001793A HN 2008001793 A HN2008001793 A HN 2008001793A HN 2008001793 A HN2008001793 A HN 2008001793A HN 2008001793 A HN2008001793 A HN 2008001793A HN 2008001793 A HN2008001793 A HN 2008001793A
Authority
HN
Honduras
Prior art keywords
mdo
modified
enzyme
dmo
dicamba
Prior art date
Application number
HN2008001793A
Other languages
English (en)
Spanish (es)
Inventor
Thomas Clemente
Razvan Dumitri
Paul Feng
Stainlaw Flansinski
Donalds P Weeks
Original Assignee
Monsanto Technology Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Technology Llc filed Critical Monsanto Technology Llc
Publication of HN2008001793A publication Critical patent/HN2008001793A/es

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HN2008001793A 2006-06-06 2008-12-05 Enzima mdo modificada y metodo para su utilizacion HN2008001793A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81115206P 2006-06-06 2006-06-06

Publications (1)

Publication Number Publication Date
HN2008001793A true HN2008001793A (es) 2011-07-12

Family

ID=39722426

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2008001793A HN2008001793A (es) 2006-06-06 2008-12-05 Enzima mdo modificada y metodo para su utilizacion

Country Status (5)

Country Link
CN (1) CN101501196B (zh)
AR (5) AR061247A1 (zh)
ES (1) ES2359749T3 (zh)
HN (1) HN2008001793A (zh)
UA (1) UA94613C2 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010295864C1 (en) * 2009-09-17 2015-04-30 Monsanto Technology Llc Soybean transgenic event MON 87708 and methods of use thereof
CN102242133B (zh) * 2010-05-14 2013-08-07 昆山科腾生物科技有限公司 麦草畏耐受型的单加氧酶基因及其应用
BR112015015055A2 (pt) * 2012-12-21 2017-10-03 Pioneer Hi Bred Int Método para desintoxicar um herbicida análogo de auxina, método para controlar pelo menos uma erva em uma área de cultivo, método para testar uma resposta de planta a um ou mais compostos
CN105925590B (zh) * 2016-06-18 2019-05-17 北京大北农生物技术有限公司 除草剂抗性蛋白质、其编码基因及用途
CA3057917A1 (en) 2018-10-16 2020-04-16 Monsanto Technology Llc Brassica event mon94100 and methods of use thereof
CN111139238B (zh) * 2019-10-14 2021-08-03 中国农业科学院生物技术研究所 除草剂麦草畏的降解基因dicX3及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022896B1 (en) * 1997-04-04 2006-04-04 Board Of Regents Of University Of Nebraska Methods and materials for making and using transgenic dicamba-degrading organisms
US7105724B2 (en) * 1997-04-04 2006-09-12 Board Of Regents Of University Of Nebraska Methods and materials for making and using transgenic dicamba-degrading organisms

Also Published As

Publication number Publication date
AR061247A1 (es) 2008-08-13
AR096407A2 (es) 2015-12-30
UA94613C2 (ru) 2011-05-25
CN101501196B (zh) 2013-01-02
AR096405A2 (es) 2015-12-30
ES2359749T3 (es) 2011-05-26
CN101501196A (zh) 2009-08-05
AR096406A2 (es) 2015-12-30
AR087719A2 (es) 2014-04-09

Similar Documents

Publication Publication Date Title
GT200800274A (es) Enzima dmo modificada y metodos para su utilización
HN2008001793A (es) Enzima mdo modificada y metodo para su utilizacion
WO2008103041A8 (en) Recombinant gelatins
CR10290A (es) Metodos para reducir la aglomeracion de proteina
ES2572160T3 (es) Una nueva preparación farmacéutica para preeclampsia
CR11031A (es) Composiciones de enzima digestiva estable
GT200600227A (es) Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas
GT200900264A (es) Moléculas y métodos para modular la pro-proteina
CO6450665A2 (es) Anticuerpos anti-fgfr3 y métodos que los utilizan
BRPI0823506A8 (pt) composições e métodos para a produção de isoprene
CL2011002082A1 (es) Composicion farmaceutica que comprende un inhibidor de nucleosido polimerasa y un inhibidor de proteasa macrociclica; proceso para preparar dicha composicion farmaceutica; metodo para tratar o mejorar una infeccion con virus de la hepatitis c, fibrosis hepatica y alteracion de la funcion hepatica.
CR10388A (es) Composiciones antibioticas de libracion modificada y procesos para la produccion de las mismas.
CR9360A (es) Composiciones de herbicidas que contienen limoneno, formulaciones de concentrados de herbicidas y metodos para fabricar y usar las mismas.
CO6640205A2 (es) Microorganismos y metodos para la biosintesis de p-toluato y tereftalato
ES2531167T5 (es) Amilasas y glucoamilasas, ácidos nucleicos que las codifican y métodos para formarlas y utilizarlas
AR058501A1 (es) Composiciones azeotropicas que comprenden 1,1,1,2,3- pentalfluoropeno y fluoruro de hidrogeno y sus usos
WO2009114475A3 (en) Compositions comprising human pcsk9 and apolipoprotein b sirna and methods of use
MX2010000348A (es) Cultivo de celulas madre pluripotentes individuales.
BRPI0807220B1 (pt) composição, e, métodos para aumentar a força de compressão de uma composição e para aumentar a retenção de fragrância de uma composição
AR074106A1 (es) Composiciones y metodos que comprenden una variante de subtilisina
AR099500A1 (es) Composición para el desmucilaginado enzimático de aceite
FR2924118B1 (fr) Fragments d'anticorps inhibiteurs de la proteine nef du vih.
BRPI1009227A2 (pt) Microorganismos que produz l-aminoácido e método para a produção de l-aminoácido com o uso do mesmo.
AR073057A1 (es) Combinaciones insecticidas de abamectina y ciflumetofeno y composiciones que las comprenden.
CR8820A (es) Nueva asociacion de un inhibidor de la corriente sinusual l1t y de un inhibidor de la enzima de conversion y las composiciones farmaceuticas que la contienen.